Effect of Sulfated Glycoprotein-2 (Clusterin) on Apoptosis of PC3 Cell Induced by Docetaxel
PC3 세포주에서 Docetaxel에 의해 유발된 세포고사에 대한 Sulfated Glycoprotein-2 (Clusterin)의 작용에 대한 연구
최, 종보; 김, 영수; 원, 남희; 조, 재흥
Taehan Pinyogikwa Hakhoe chi, 43(7):584-590, 2002
Taehan Pinyogikwa Hakhoe chi; The Korean journal of urology; 대한비뇨기과학회지
Purpose: Sulfated glycoprotein-2 (SGP-2) is a glycoprotein that is secreted by mature mammalian Sertoli and epididymal epithelial cells, and has been previously identified as an apoptosis inhibitor. This study was undertaken to determine, whether
anti-SGP-2 antibodies in combination with a chemotherapeutic agent improves the therapeutic outcome.
Materials and Methods: Western blot analysis was performed to detect the changes in SGP-2 secretion from PC-3 cells after treating them with docetaxel (Taxotere®). The PC-3 cells were cultured and treated with various
concentrations of docetaxel with 40 ㎍/㎖ of anti-SGP-2 antibodies. In addition, the cultured PC-3 cells were treated with TNF-α at 10ng/㎖ with the SGP-2 antibodies. The number of viable cells was assessed by a trypan blue dye extraction assay after 24 hours. Using flowcytometric analysis, the exact extent of and changes in apoptosis after treatment with the anti-SGP-2 antibodies were assessed.
Results: The percentage of viable PC-3 cells treated with docetaxel decreased with increasing docetaxel concentration. The percentage of viable PC-3 cells treated with docetaxel and anti-SGP-2 antibodies was lower in proportion to the docetaxel
concentration. However these two groups were not statistically different. The percentage of viable PC-3 cells incubated with 10ng/㎖ TNF-α and the anti-SGP-2 antibodies were significantly lower compared to that for TNF-α alone (p<0.05). In the FACScan analysis, the number of apoptotic cells was not higher in the PC3 cells treated with docetaxel and anti SGP-2 antibodies compared to those treated with docetaxel alone.
Conclusions: These results showed that SGP-2 prevents TNF-α induced apoptosis primarily. However no difference in apoptosis between the docetaxel treated PC-3 cells and the docetaxel with the anti-SGP-2 antibodies treated PC-3 cells was observed. Therefore, the treatment outcome may not be improved by the combined therapy, involving blocking SGP-2 with Taxane based chemotherapy with the same cytotoxic mechanism as docetaxel.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Total Visit :2,787,207
Total Download :1,136,409
Today View :890
Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312 / FAX : 031-219-5314 Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved. AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.